| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXNX | Common Stock | Options Exercise | $284K | +20K | +200% | $14.19* | 30K | Feb 1, 2022 | Direct | |
| transaction | AXNX | Common Stock | Sale | -$94.5K | -2.02K | -6.72% | $46.83 | 28K | Feb 1, 2022 | Direct | F1, F2 |
| transaction | AXNX | Common Stock | Sale | -$180K | -3.73K | -13.33% | $48.26 | 24.3K | Feb 1, 2022 | Direct | F1, F3 |
| transaction | AXNX | Common Stock | Sale | -$680K | -13.9K | -57.12% | $49.07 | 10.4K | Feb 1, 2022 | Direct | F1, F4 |
| transaction | AXNX | Common Stock | Sale | -$19.9K | -400 | -3.85% | $49.70 | 10K | Feb 1, 2022 | Direct | F1, F5 |
| transaction | AXNX | Common Stock | Award | $0 | +11K | +110% | $0.00 | 21K | Jan 31, 2022 | Direct | |
| transaction | AXNX | Common Stock | Options Exercise | $0 | +36.9K | +369.19% | $0.00 | 46.9K | Feb 3, 2022 | Direct | |
| transaction | AXNX | Common Stock | Sale | -$855K | -17.7K | -37.8% | $48.21 | 29.2K | Feb 3, 2022 | Direct | F6, F7 |
| transaction | AXNX | Common Stock | Sale | -$46.4K | -947 | -3.25% | $49.03 | 28.2K | Feb 3, 2022 | Direct | F6, F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXNX | Stock Option (Right to Buy) | Options Exercise | $0 | -20K | -38.12% | $0.00 | 32.5K | Feb 1, 2022 | Common Stock | 20K | $14.19 | Direct | F9 |
| transaction | AXNX | Performance-Based Restricted Stock Units | Award | $0 | +5.25K | $0.00 | 5.25K | Jan 31, 2022 | Common Stock | 5.25K | Direct | F10 | ||
| transaction | AXNX | Performance-Based Restricted Stock Units | Award | $0 | +5.25K | $0.00 | 5.25K | Jan 31, 2022 | Common Stock | 5.25K | Direct | F11 | ||
| transaction | AXNX | Performance-Based Restricted Stock Units | Options Exercise | $0 | -10.8K | -100% | $0.00* | 0 | Feb 3, 2022 | Common Stock | 10.8K | Direct | F12 | |
| transaction | AXNX | Performance-Based Restricted Stock Units | Options Exercise | $0 | -26.1K | -100% | $0.00* | 0 | Feb 3, 2022 | Common Stock | 26.1K | $0.00 | Direct | F13 |
| Id | Content |
|---|---|
| F1 | The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. |
| F10 | Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023. |
| F11 | The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024. |
| F12 | Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022. |
| F13 | The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2021, and provided the reporting person remains in continuous service through December 31, 2021. |
| F2 | This transaction was executed in multiple trades at prices ranging from $46.475 to $47.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $47.66 to $48.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $48.66 to $49.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $49.66 to $49.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein. |
| F7 | This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date. |